Study published in Journal of Extracellular Vesicles validates platform for new class of liquid biopsy: multiomic disease biology of living cells from ...
Andelyn Biosciences (“Andelyn”), a leading US-based patient-focused cell and gene therapy Contract Development and Manufacturing Organization (...
Initiated a Phase 1/2 clinical trial to enroll healthy volunteers and patients with Urea Cycle Disorders of any mutational background Administered...
Joint venture between Reset Health and Pharmacy2U creates the first and only fully integrated national cardiometabolic care provider. Averly Health will...
SkinHealth Systems (Nasdaq: SKIN), home to flagship brand Hydrafacial™, announced the European expansion of the SkinStylus® SteriLock® MicroS...
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, announced that Tandem Mobi, the world’s smalle...
BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) announced that Leqembi is now available at a private clinic in Sweden and that the first patie...
As biologics and novel modalities become increasingly sophisticated, understanding molecular structure under controlled conditions tells only part ...
For emerging biopharma companies, speed, quality and scalability cannot be treated as separate priorities. As products progress t...
Sygnature Discovery, a leading integrated drug discovery contract research organisation (CRO), has established a formal collaboration with X-Chem, a data...
SK pharmteco recently hosted a formal ribbon-cutting ceremony to mark the official opening of two major facility expansions at its manufacturing campus i...
Skye Bioscience, Inc., and Redx Pharma Limited (“Redx”), a U.K. based, privately-held clinical-stage biotechnology company focused on develop...
Aqemia, the drug invention company combining generative AI and quantum-inspired physics to invent small molecule drugs, announced the expansion of its mu...
While we will need to wait for the National Commission into the Regulation of AI in Healthcare's recommendations later this summer, and then the MH...
© 2026 Biopharma Boardroom. All Rights Reserved.
